Obesity hypoventilation syndrome

Juan F Masa, Jean-Louis Pépin, Jean-Christian Borel, Babak Mokhlesi, Patrick B Murphy, Maria Ángeles Sánchez-Quiroga, Juan F Masa, Jean-Louis Pépin, Jean-Christian Borel, Babak Mokhlesi, Patrick B Murphy, Maria Ángeles Sánchez-Quiroga

Abstract

Obesity hypoventilation syndrome (OHS) is defined as a combination of obesity (body mass index ≥30 kg·m-2), daytime hypercapnia (arterial carbon dioxide tension ≥45 mmHg) and sleep disordered breathing, after ruling out other disorders that may cause alveolar hypoventilation. OHS prevalence has been estimated to be ∼0.4% of the adult population. OHS is typically diagnosed during an episode of acute-on-chronic hypercapnic respiratory failure or when symptoms lead to pulmonary or sleep consultation in stable conditions. The diagnosis is firmly established after arterial blood gases and a sleep study. The presence of daytime hypercapnia is explained by several co-existing mechanisms such as obesity-related changes in the respiratory system, alterations in respiratory drive and breathing abnormalities during sleep. The most frequent comorbidities are metabolic and cardiovascular, mainly heart failure, coronary disease and pulmonary hypertension. Both continuous positive airway pressure (CPAP) and noninvasive ventilation (NIV) improve clinical symptoms, quality of life, gas exchange, and sleep disordered breathing. CPAP is considered the first-line treatment modality for OHS phenotype with concomitant severe obstructive sleep apnoea, whereas NIV is preferred in the minority of OHS patients with hypoventilation during sleep with no or milder forms of obstructive sleep apnoea (approximately <30% of OHS patients). Acute-on-chronic hypercapnic respiratory failure is habitually treated with NIV. Appropriate management of comorbidities including medications and rehabilitation programmes are key issues for improving prognosis.

Conflict of interest statement

Conflict of interest: J.F. Masa has nothing to disclose. Conflict of interest: J-L. Pépin reports grants and research funds from Air Liquide Foundation, Agiradom, AstraZeneca, Fisher and Paykel, Mutualia, Philips and Resmed. He has also received fees from Agiradom, AstraZeneca, Boehringer Ingelheim, Jazz pharmaceutical, Night Balance, Philips, Resmed and Sefam. Conflict of interest: J-C. Borel reports grants and personal fees from Philips, personal fees and other fees from Resmed, and other fees from AGIR à dom (for salaries) and NOMICS (for patents), outside the submitted work. Conflict of interest: B. Mokhlesi has nothing to disclose. Conflict of interest: P.B. Murphy reports grants and personal fees from Philips and Resmed, and personal fees from Fisher-Paykel, outside the submitted work. Conflict of interest: M.A. Sánchez Quiroga has nothing to disclose.

Copyright ©ERS 2019.

Figures

FIGURE 1
FIGURE 1
Management of patients with obesity hypoventilation syndrome (OHS) from diagnosis to integrated care to modify health trajectories. After being diagnosed with OHS, these patients are typically initiated on positive airway pressure (PAP) therapy (continuous positive airway pressure or noninvasive ventilation). Although respiratory insufficiency improves quite consistently in patients adherent to PAP therapy, pulmonary hypertension may also improve in some patients with OHS. There is no evidence that other cardiovascular and metabolic comorbidities improve with PAP treatment alone. Therefore, a multimodality therapeutic approach is necessary to combine PAP therapy with strategies aimed at weight reduction and increased physical activity. PaCO2: arterial carbon dioxide tension.
FIGURE 2
FIGURE 2
Pathophysiology of obesity hypoventilation syndrome (OHS). The implicated mechanisms leading to daytime hypercapnia are, potentially, the obesity-related changes in the respiratory system, central hypoventilation, obstructive sleep apnoeas and hypoventilation during sleep, mainly during rapid eye movement (REM). PEEPi: intrinsic positive end-expiratory pressure; PaO2: arterial oxygen tension; FRC: functional residual capacity; ERV: expiratory reserve volume; RV: residual volume; TLC: total lung capacity.
FIGURE 3
FIGURE 3
Obesity hypoventilation syndrome (OHS) management strategy. Continuous positive airway pressure (CPAP) could be first-line treatment for OHS patients with concomitant severe obstructive sleep apnoea (OSA). Noninvasive ventilation (NIV) should be considered as first-line therapy for OHS patients with no OSA or milder forms of OSA. If patients initially treated with CPAP have no favourable response to therapy despite objectively documented high levels of adherence to CPAP, they should be changed to NIV therapy. AHI: apnoea–hypopnoea index.
FIGURE 4
FIGURE 4
Positive airway pressure adjustment in acute decompensated obesity-related respiratory failure. The adjustment of continuous positive airway pressure/expiratory positive airway pressure (EPAP) has the objective of eliminating obstructive events, snoring and intermittent oxygen desaturations. Adjustments in inspiratory positive airway pressure (IPAP) are aimed at eliminating hypoventilation and sustained hypoxaemia. For both EPAP and IPAP, the pressure should increase progressively until attaining the objectives (resolution of upper airway obstructive events and sleep hypoventilation) or until the maximal tolerated pressure is reached. Alternatively, EPAP/continuous positive airway pressure can be adjusted to eliminate obstructive apnoeas and IPAP can be further increased to eliminate obstructive hyponoeas, snoring and hypoventilation. With this strategy, the patient may require lower EPAP and therefore achieve higher levels of pressure support in order to improve hypoventilation [96]. Supplemental oxygen is habitually added to positive airway pressure therapy when an adequate oxygenation level is not achieved despite adequate titration of positive airway pressure therapy. NIV: noninvasive ventilation; PaO2: arterial oxygen tension; SaO2: arterial oxygen saturation.

References

    1. Mokhlesi B, Kryger MH, Grunstein RR. Assessment and management of patients with obesity hypoventilation syndrome. Proc Am Thorac Soc 2008; 5: 218–225.
    1. Masa JF, Corral J, Alonso ML, et al. . Efficacy of different treatment alternatives for obesity hypoventilation syndrome. Pickwick Study. Am J Respir Crit Care Med 2015; 192: 86–95.
    1. Berry RB, Budhiraja R, Gottlieb DJ, et al. . Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2012; 8: 597–619.
    1. Randerath W, Verbrechen J, Andreas S, et al. . Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J 2017; 49: 1600959.
    1. Sturm R. Increases in morbid obesity in the USA: 2000–2005. Public Health 2007; 121: 492–496.
    1. Hales CM, Fryar CD, Carroll MD, et al. . Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the United States, 2013–2016. JAMA 2018; 319: 2419–2429.
    1. Balachandran JS, Masa JF, Mokhlesi B. Obesity hypoventilation syndrome: epidemiology and diagnosis. Sleep Med Clin 2014; 9: 341–347.
    1. Harada Y, Chihara Y, Azuma M, et al. . Obesity hypoventilation syndrome in Japan and independent determinants of arterial carbon dioxide levels. Respirology 2014; 19: 1233–1240.
    1. BaHammam AS. Prevalence, clinical characteristics, and predictors of obesity hypoventilation syndrome in a large sample of Saudi patients with obstructive sleep apnea. Saudi Med J 2015; 36: 181–189.
    1. Kaw R, Hernandez AV, Walker E, et al. . Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and meta analysis of cohort studies. Chest 2009; 136: 787–796.
    1. Akashiba T, Akahoshi T, Kawahara S, et al. . Clinical characteristics of obesity-hypoventilation syndrome in Japan: a multi-center study. Intern Med 2006; 45: 1121–1125.
    1. Palm A, Midgren B, Janson C, et al. . Gender differences in patients starting long-term home mechanical ventilation due to obesity hypoventilation syndrome. Respir Med 2016; 110: 73–78.
    1. BaHammam AS, Pandi-Perumal SR, Piper A, et al. . Gender differences in patients with obesity hypoventilation syndrome. J Sleep Res 2016; 25: 445–453.
    1. Borel JC, Guerber F, Jullian-Desayes I, et al. . Prevalence of obesity hypoventilation syndrome in ambulatory obese patients attending pathology laboratories. Respirology 2017; 22: 1190–1198.
    1. Lee WY, Mokhlesi B. Diagnosis and management of obesity hypoventilation syndrome in the ICU. Crit Care Clin 2008; 24: 533–549.
    1. Mokhlesi B. Obesity hypoventilation syndrome: a state-of-the-art review. Respir Care 2010; 55: 1347–1362.
    1. Marik PE, Desai H. Characteristics of patients with the “malignant obesity hypoventilation syndrome” admitted to an ICU. J Intensive Care Med 2013; 28: 124–130.
    1. Mokhlesi B, Tulaimat A, Faibussowitsch I, et al. . Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 2007; 11: 117–124.
    1. Macavei VM, Spurling KJ, Loft J, et al. . Diagnostic predictors of obesity-hypoventilation syndrome in patients suspected of having sleep disordered breathing. J Clin Sleep Med 2013; 9: 879–884.
    1. Hollier CA, Maxwell LJ, Harmer AR, et al. . Validity of arterialised-venous PCO2, pH and bicarbonate in obesity hypoventilation syndrome. Respir Physiol Neurobiol 2013; 188: 165–171.
    1. Huttmann SE, Windisch W, Storre JH. Techniques for the measurement and monitoring of carbon dioxide in the blood. Ann Am Thorac Soc 2014; 11: 645–652.
    1. Piper AJ, Gonzalez-Bermejo J, Janssens JP. Sleep hypoventilation: diagnostic considerations and technological limitations. Sleep Med Clin 2014; 9: 301–314.
    1. Pepin JL, Timsit JF, Tamisier R, et al. . Prevention and care of respiratory failure in obese patients. Lancet Respir Med 2016; 4: 407–418.
    1. Hodgson LE, Murphy PB, Hart N. Respiratory management of the obese patient undergoing surgery. J Thorac Dis 2015; 7: 943–952.
    1. Zavorsky GS, Hoffman SL. Pulmonary gas exchange in the morbidly obese. Obes Rev 2008; 9: 326–339.
    1. Masa JF, Corral J, Caballero C, et al. . Non-invasive ventilation in obesity hypoventilation syndrome without severe obstructive sleep apnoea. Thorax 2016; 71: 899–906.
    1. Levy P, Kohler M, McNicholas WT, et al. . Obstructive sleep apnoea syndrome. Nat Rev Dis Primers 2015; 1: 15015.
    1. White LH, Bradley TD. Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea. J Physiol (Lond) 2013; 591: 1179–1193.
    1. Ayappa I, Berger KI, Norman RG, et al. . Hypercapnia and ventilatory periodicity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2002; 166: 1112–1115.
    1. Berger KI, Ayappa I, Sorkin IB, et al. . Post event ventilation as a function of CO(2) load during respiratory events in obstructive sleep apnea. J ApplPhysiol (1985) 2002; 93: 917–924.
    1. Borel JC, Tamisier R, Gonzalez-Bermejo J, et al. . Noninvasive ventilation in mild obesity hypoventilation syndrome: a randomized controlled trial. Chest 2012; 141: 692–702.
    1. Jennum P, Kjellberg J. Health, social and economical consequences of sleep-disordered breathing: a controlled national study. Thorax 2011; 66: 560–566.
    1. Borel JC, Burel B, Tamisier R, et al. . Comorbidities and mortality in hypercapnia obese under domiciliary noninvasive ventilation. PLoS One 2013; 8: e52006.
    1. Castro-Añón O, Perez de Llano LA, De la Fuente-Sanchez D, et al. . Obesity hypoventilation syndrome: increased risk of death over sleep apnea syndrome. PLoS One 2015; 10: e0117808.
    1. Basoglu OK, Tasbakan MS. Comparison of clinical characteristics in patients with obesity hypoventilation syndrome and obese obstructive sleep apnea syndrome: a case-control study. Clin Respir J 2014; 8: 167–174.
    1. Berg G, Delaive K, Manfreda J, et al. . The use of health-care resources in obesity-hypoventilation syndrome. Chest 2001; 120: 377–383.
    1. Nowbar S, Burkart KM, Gonzales R, et al. . Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med 2004; 116: 1–7.
    1. Pérez de Llano LA, Golpe R, Ortiz-Piquer M, et al. . Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest 2005; 128: 587–594.
    1. Mokhlesi B, Tulaimat A, Evans AT, et al. . Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea. J Clin Sleep Med 2006; 2: 57–62.
    1. Trakada GP, Steiropoulos P, Nena E, et al. . Prevalence and clinical characteristics of obesity hypoventilation syndrome among individuals reporting sleep-related breathing symptoms in northern Greece. Sleep Breath 2010; 14: 381–386.
    1. Salord N, Mayos M, Miralda RM, et al. . Continuous positive airway pressure in clinically stable patients with mild-to-moderate obesity hypoventilation syndrome and obstructive sleep apnoea. Respirology 2013; 18: 1135–1142.
    1. Priou P, Hamel JF, Person C, et al. . Long-term outcome of noninvasive positive pressure ventilation for obesity hypoventilation syndrome. Chest 2010; 138: 84–90.
    1. Jennum P, Ibsen R, Kjellberg J. Morbidity prior to a diagnosis of sleep-disordered breathing: a controlled national study. J Clin Sleep Med 2013; 9: 103–108.
    1. Masa JF, Corral J, Romero A, et al. . Protective cardiovascular effect of sleep apnea severity in obesity hypoventilation syndrome. Chest 2016; 150: 68–79.
    1. Castro-Añón O, Golpe R, Pérez-de-Llano LA, et al. . Haemodynamic effects of non-invasive ventilation in patients with obesity-hypoventilations syndrome. Respirology 2012; 17: 1269–1274.
    1. Corral J, Mogollon MV, Sánchez-Quiroga MÁ, et al. . Echocardiographic changes with non-invasive ventilation and CPAP in obesity hypoventilation syndrome. Thorax 2018; 73: 361–368.
    1. Kessler R, Chaouat A, Schinkewitch P, et al. . The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest 2001; 120: 369–376.
    1. Mandal S, Suh ES, Harding R, et al. . Nutrition and Exercise Rehabilitation in Obesity hypoventilation syndrome (NERO): a pilot randomised controlled trial. Thorax 2018; 73: 62–69.
    1. Borel JC, Borel AL, Piper AJ. NERO: a pilot study but important step towards comprehensive management of obesity hypoventilation syndrome. Thorax 2018; 73: 5–6.
    1. Vivodtzev I, Tamisier R, Croteau M, et al. . Ventilatory support or respiratory muscle training as adjuncts to exercise in obese CPAP-treated patients with obstructive sleep apnoea: a randomized controlled trial. Thorax 2018; doi:10.1136/thoraxjnl-2017-211152.
    1. Carrillo A, Ferrer M, Gonzalez-Diaz G, et al. . Noninvasive ventilation in acute hypercapnic respiratory failure caused by obesity hypoventilation syndrome and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186: 1279–1285.
    1. Marik PE, Chen C. The clinical characteristics and hospital and post-hospital survival of patients with the obesity hypoventilation syndrome: analysis of a large cohort. Obes Sci Pract 2016; 2: 40–47.
    1. Piper AJ, Grunstein RR. Obesity hypoventilation syndrome: mechanisms and management. Am J Respir Crit Care Med 2011; 183: 292–298.
    1. Mokhlesi B, Tulaimat A. Recent advances in obesity hypoventilation syndrome. Chest 2007; 132: 1322–1336.
    1. Berger KI, Goldring RM, Rapoport DM. Obesity hypoventilation syndrome. Semin Respir Crit Care Med 2009; 30: 253–261.
    1. Berry RB, Chediak A, Brown LK, et al. . Best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (NPPV) in stable chronic alveolar hypoventilation syndromes. J Clin Sleep Med 2010; 6: 491–509.
    1. Budweiser S, Riedl SG, Jörres RA, et al. . Mortality and prognostic factors in patients with obesity-hypoventilation syndrome undergoing noninvasive ventilation. J Intern Med 2007; 261: 375–383.
    1. Berger KI, Ayappa I, Chatr-Amontri B, et al. . Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. Chest 2001; 120: 1231–1238.
    1. Heinemann F, Budweiser S, Dobroschke J, et al. . Non-invasive positive pressure ventilation improves lung volumes in the obesity hypoventilation syndrome. Respir Med 2007; 101: 1229–1235.
    1. Janssens JP, Derivaz S, Breitenstein E, et al. . Changing patterns in long-term noninvasive ventilation: a 7-year prospective study in the Geneva Lake area. Chest 2003; 123: 67–79.
    1. Ojeda Castillejo E, de Lucas Ramos P, López Martin S, et al. . Noninvasive mechanical ventilation in patients with obesity hypoventilation syndrome. Long-term outcome and prognostic factors. Arch Bronconeumol 2015; 51: 61–68.
    1. Sugerman HJ, Baron PL, Fairman RP, et al. . Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss. Ann Surg 1988; 207: 604–613.
    1. Kauppert CA, Dvorak I, Kollert F, et al. . Pulmonary hypertension in obesity-hypoventilation syndrome. Respir Med 2013; 107: 2061–2070.
    1. Alawami M, Mustafa A, Whyte K, et al. . Echocardiographic and electrocardiographic findings in patients with obesity hypoventilation syndrome. Intern Med J 2015; 45: 68–73.
    1. Piper AJ, Wang D, Yee BJ, et al. . Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax 2008; 63: 395–401.
    1. Howard ME, Piper AJ, Stevens B, et al. . A randomized controlled trial of CPAP versus non-invasive ventilation for initial treatment of obesity hypoventilation syndrome. Thorax 2017; 72: 437–444.
    1. Sánchez-Quiroga MÁ, Mokhlesi B, Corral J, et al. . CPAP vs NIV for long term treatment of obesity hypoventilation syndrome: the results of the Pickwick randomized controlled trial. Am J Respir Crit Care Med 2018; 197: A1042.
    1. Masa JF, Mokhlesi B, Gomez de Terreros FJ, et al. . Long-term positive airway pressure therapy in obesity hypoventilation syndrome: the Pickwick Randomised Clinical Trial. Lancet 2019; in press.
    1. Storre JH, Seuthe B, Fiechter R, et al. . Average volume-assured pressure support in obesity hypoventilation: a randomized crossover trial. Chest 2006; 130: 815–821.
    1. Janssens JP, Metzger M, Sforza E. Impact of volume targeting on efficacy of bi-level non-invasive ventilation and sleep in obesity-hypoventilation. Respir Med 2009; 103: 165–172.
    1. Ambrogio C, Lowman X, Kuo M, et al. . Sleep and non-invasive ventilation in patients with chronic respiratory insufficiency. Intensive Care Med 2009; 35: 306–313.
    1. Murphy PB, Davidson C, Hind MD, et al. . Volume targeted versus pressure support non-invasive ventilation in patients with super obesity and chronic respiratory failure: a randomised controlled trial. Thorax 2012; 67: 727–734.
    1. Kelly JL, Jaye J, Pickersgill RE, et al. . Randomized trial of “intelligent” autotitrating ventilation versus standard pressure support non-invasive ventilation: impact on adherence and physiological outcomes. Respirology 2014; 19: 596–603.
    1. McArdle N, Rea C, King S, et al. . Treating chronic hypoventilation with automatic adjustable versus fixed EPAP intelligent volume-assured positive airway pressure support (iVAPS): a randomized controlled trial. Sleep 2017; 40: zsx136.
    1. Murphy PB, Arbane G, Ramsay M, et al. . Safety and efficacy of auto-titrating noninvasive ventilation in COPD and obstructive sleep apnoea overlap syndrome. Eur Respir J 2015; 46: 548–551.
    1. Patout M, Gagnadoux F, Rabec C, et al. . AVAPS-AE vs. ST mode: a randomised controlled trial in patients with obesity hypoventilation syndrome. Eur Respir J 2018; 52: Suppl. 62, PA1674.
    1. Mandal S, Arbane G, Murphy P, et al. . Medium-term cost-effectiveness of an automated non-invasive ventilation outpatient set-up versus a standard fixed level non-invasive ventilation inpatient set-up in obese patients with chronic respiratory failure: a protocol description. BMJ Open 2015; 5: e007082.
    1. Sampson MG, Grassino K. Neuromechanical properties in obese patients during carbon dioxide rebreathing. Am J Med 1983; 75: 81–90.
    1. Steier J, Jolley CJ, Seymour J, et al. . Neural respiratory drive in obesity. Thorax 2009; 64: 719–725.
    1. Steier J, Lunt A, Hart N, et al. . Observational study of the effect of obesity on lung volumes. Thorax 2014; 69: 752–759.
    1. Sharp JT, Henry JP, Sweany SK, et al. . The total work of breathing in normal and obese men. J Clin Invest 1964; 43: 728–739.
    1. Kawata N, Tatsumi K, Terada J, et al. . Daytime hypercapnia in obstructive sleep apnea syndrome. Chest 2007; 132: 1832–1838.
    1. Drager LF, Brunoni AR, Jenner R, et al. . Effects of CPAP on body weight in patients with obstructive sleep apnoea: a meta-analysis of randomised trials. Thorax 2015; 70: 258–264.
    1. Quan SF, Budhiraja R, Clarke DP, et al. . Impact of treatment with continuous positive airway pressure (CPAP) on weight in obstructive sleep apnea. J Clin Sleep Med 2013; 9: 989–993.
    1. West SD, Kohler M, Nicoll DJ, et al. . The effect of continuous positive airway pressure treatment on physical activity in patients with obstructive sleep apnoea: a randomised controlled trial. Sleep Med 2009; 10: 1056–1058.
    1. Jordan KE, Ali M, Shneerson JM. Attitudes of patients towards a hospital-based rehabilitation service for obesity hypoventilation syndrome. Thorax 2009; 64: 1007.
    1. Picot J, Jones J, Colquitt JL, et al. . The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009; 13: 1–190.
    1. Ashrafian H, Toma T, Rowland SP, et al. . Bariatric surgery or non-surgical weight loss for obstructive sleep apnoea? A systematic review and comparison of meta-analyses. Obes Surg 2015; 25: 1239–1250.
    1. Adams TD, Davidson LE, Litwin SE, et al. . Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med 2017; 377: 1143–1155.
    1. Kaw R, Bhateja P, Paz YMH, et al. . Postoperative complications in patients with unrecognized obesity hypoventilation syndrome undergoing elective noncardiac surgery. Chest 2016; 149: 84–91.
    1. Mokhlesi B, Hovda MD, Vekhter B, et al. . Sleep-disordered breathing and postoperative outcomes after elective surgery: analysis of the nationwide inpatient sample. Chest 2013; 144: 903–914.
    1. Sugerman HJ, Fairman RP, Lindeman AK, et al. . Gastroplasty for respiratory insufficiency of obesity. Ann Surg 1981; 193: 677–685.
    1. Anttalainen U, Saaresranta T, Vahlberg T, et al. . Short-term medroxyprogesterone acetate in postmenopausal women with sleep-disordered breathing: a placebo-controlled, randomized, double-blind, parallel-group study. Menopause 2014; 21: 361–368.
    1. Raurich JM, Rialp G, Ibanez J, et al. . Hypercapnic respiratory failure in obesity-hypoventilation syndrome: CO(2) response and acetazolamide treatment effects. Respir Care 2010; 55: 1442–1448.
    1. Hollier CA, Harmer AR, Maxwell LJ, et al. . Moderate concentrations of supplemental oxygen worsen hypercapnia in obesity hypoventilation syndrome: a randomised crossover study. Thorax 2014; 69: 346–353.
    1. Davidson AC, Banham S, Elliott M, et al. . BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults. Thorax 2016; 71: Suppl. 2, ii1–i35.
    1. Lemyze M, Taufour P, Duhamel A, et al. . Determinants of noninvasive ventilation success or failure in morbidly obese patients in acute respiratory failure. PLoS One 2014; 9: e97563.
    1. Sakr Y, Alhussami I, Nanchal R, et al. . Being overweight is associated with greater survival in ICU patients: results from the intensive care over nations audit. Crit Care Med 2015; 43: 2623–2632.
    1. Duarte AG, Justino E, Bigler T, et al. . Outcomes of morbidly obese patients requiring mechanical ventilation for acute respiratory failure. Crit Care Med 2007; 35: 732–737.
    1. Bouloukaki I, Mermigkis C, Michelakis S, et al. . The association between adherence to positive airway pressure therapy and long-term outcomes in patients with obesity hypoventilation syndrome: a prospective observational study. J Clin Sleep Med 2018; 14: 1539–1550.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe